Joshua M. Stuart
Artificial Intelligence · 2001–2020
A researcher in the Science corpus: 36 papers; trusts 1 researcher and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Artificial Intelligence — 34 citations into it
- Statistics and Probability — 22 citations into it
Whom Joshua M. Stuart trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Joshua M. Stuart overall
- Alan J. Filipski
- Steve Horvath
- Koh Aoki
- Peter Langfelder
- Koyel Mitra
- A. Ramasamy
- Hulin Wu
- Peer Bork
- Sudhir Kumar
- Ann Hammonds
Papers from Joshua M. Stuart's perspective
Ordered by how strongly the researchers Joshua M. Stuart trusts endorse each paper. Same corpus, a different order for every researcher.
- A CENSUS OF HUMAN CANCER GENES (Nature Reviews. Cancer)
- dbSNP: the NCBI database of genetic variation
- Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation (Cancer Cell)
- Genetic basis for clinical response to CTLA-4 blockade in melanoma. (New England Journal of Medicine)
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer (Nature Genetics)
- Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. (Journal of the National Cancer Institute)
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers (Genome Biology)
- Human protein reference database—2006 update (Nucleic Acids Res.)
- The hallmarks of cancer (RNA Biology)
Their papers
- A Gene Expression Map for Caenorhabditis elegans (2001) — 707 citations
- A Gene-Coexpression Network for Global Discovery of Conserved Genetic Modules (2003) — 2,285 citations
- PharmGKB: the Pharmacogenetics Knowledge Base (2002) — 436 citations
- Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM (2010) — 781 citations
- Comprehensive molecular portraits of human breast tumors (2012) — 7,518 citations
- Comprehensive Molecular Characterization of Human Colon and Rectal Cancer (2012) — 7,754 citations
- International network of cancer genome projects (2010) — 2,229 citations
- Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer (2018) — 2,163 citations
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) — 792 citations
- Pathway and Network Analysis of Cancer Genomes (2015) — 319 citations
- Inferring causal molecular networks: empirical assessment through a community-based effort (2016) — 222 citations
- Integrated Genomic Analyses of Ovarian Carcinoma (2011) — 7,559 citations
- Comprehensive molecular profiling of lung adenocarcinoma (2014) — 5,176 citations
- Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation (2018) — 1,865 citations
- Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) — 2,007 citations
- Genomic Classification of Cutaneous Melanoma (2015) — 2,764 citations
- Functionally distinct subsets of lineage-biased multipotent progenitors control blood production in normal and regenerative conditions (2015) — 637 citations
- Integrated Genomic Characterization of Papillary Thyroid Carcinoma (2014) — 2,692 citations
- Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection (2015) — 314 citations
- Comprehensive Molecular Characterization of Urothelial Bladder Carcinoma (2014) — 2,001 citations